ADVISORY/Study Seeks Persons with Multiple Sclerosis for Local Trial of ILEX Oncology Drug.News Editors/Health/Medical Writers ADVISORY... --(BUSINESS WIRE) ILEX Ilex a bush bearing berries containing saponins; cause vomiting, diarrhea. Called also holly. Oncology oncology /on·col·o·gy/ (ong-kol´ah-je) the sum of knowledge regarding tumors; the study of tumors. on·col·o·gy n. Inc. (Nasdaq:ILXO) Persons with multiple sclerosis multiple sclerosis (MS), chronic, slowly progressive autoimmune disease in which the body's immune system attacks the protective myelin sheaths that surround the nerve cells of the brain and spinal cord (a process called demyelination), resulting in damaged areas in the Orlando area may be interested in a new drug study underway here. A local physician, Dr. Daniel Jacobs Dan Jacobs (born 1942) an internationally acclaimed jazz trumpet recording artist, composer and producer who has toured extensively worldwide with various groups.[1] He also plays flugelhorn. of Neurological neurological, neurologic pertaining to or emanating from the nervous system or from neurology. neurological assessment evaluation of the health status of a patient with a nervous system disorder or dysfunction. Services of Orlando, is one of only 20 neurologists This is a list of the most important neurologists, with their dates of birth and death and nationality.
The drug being tested in the study may have the potential to slow or stop progression of MS.
What: Persons with MS may be interested in a new drug study under
way in Orlando
Who: A local physician, Dr. Daniel Jacobs of Neurological Services
of Orlando, is one of only 20 neurologists participating in an
international drug study in patients with multiple sclerosis --
a disease that impacts a reported 350,000 Americans, most of
them women.
When: Study is now underway
Where: Dr. Jacobs' offices at 1111 S. Orange Avenue, #300,
Orlando 32806
How: People with MS who want to determine whether they qualify for
the study should call Sharon Parrisch-Kach at Dr. Jacobs'
office at 407/540-1097. To interview Dr. Jacobs, call either
Sharon Parrisch-Kach or Barry Cohen of ILEX Oncology Inc. at
210/949-8239.
|
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion